Finzati - Logo
KRYS logo

Krystal Biotech, Inc.

KRYS • Biotechnology
$358.24
▼ -13.23 (-3.56%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$10.98B
Growth
—
Cash Flow
2/5
Trend
Volatile
Evidence
Stable or improving margins · 52.6%Positive revenue growth · 168.3%Positive free cash flow · 6.53Manageable debt level · 0.01Healthy liquidity · 9.95
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$358.24
Change-3.56%
Shares Out30.66M
Market Cap$10.98B
Enterprise Value$10.14B
52W Range132.31 - 382.54
Beta0.54
P/E45.48
P/S24.93
P/B8.08
P/FCF42.60
EV/Sales23.02

Investment DNA

How strong this company looks for long-term investors

75
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
30/100
Why this score▼
Stable or improving margins · 52.6%Positive revenue growth · 168.3%Positive free cash flow · 6.53Manageable debt level · 0.01Healthy liquidity · 9.95

Analyst view

Analyst sentiment and price target

KRYS
Analyst sentiment
Based on 17 analyst votes · 2026-09-05
100/100
Bullish
Bullish
17
Hold
0
Bearish
0
Price Target
2026-08-05
Low
$300.00
Mean
$364.50
Median
$342.00
High
$474.00

Company Overview

IPO: 9/20/2017
Industry: Biotechnology
P/B i: 8.08
Debt / Equity i: 0.01
Operating Margin: 41.45%
Net Margin: 52.64%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.01
Current Ratio: 9.95
Quick Ratio: 9.56
Status: Good

Insider Transactions

Recent executive and insider activity

Thomas John Charles
Transaction: 06/25/2026
SELL
Change
-1,000
Price
$347.27
Filing
06/26/2026
Type
SELL
Thomas John Charles
Transaction: 06/25/2026
SELL
Change
-1,000
Price
$179.25
Filing
06/26/2026
Type
SELL
Krishnan Krish S
Transaction: 06/04/2026
SELL
Change
-40
Price
$312.23
Filing
06/05/2026
Type
SELL